title: Fragment-based drug discovery.
authors.affiliation: Sunesis Pharmaceuticals Inc., 341 Oyster Point Boulevard, South San Francisco, CA 94080, USA. erlanson@sunesis.com
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Erlanson
authors.forename: Robert S
authors.initials: RS
authors.lastname: McDowell
authors.forename: Tom
authors.initials: T
authors.lastname: O'Brien
mesh_terms: D000818:Animals; D018360:Crystallography, X-Ray; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000138:chemical synthesis* / Q000737:chemistry* / Q000494:pharmacology; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D008970:Molecular Weight; D011485:Protein Binding; D013329:Structure-Activity Relationship; D013678:Technology, Pharmaceutical
chemical_list: D004791:Enzyme Inhibitors